The grant extension will expand applications in research, clinical trials, registries and national collaborations.
A Q&A with Vanderbilt Imaging Services’ EB Jackson, MBA, President, and Morgan Anderson, MD, Medical Director.
The collaboration will center on the Molecular AI Initiative’s pioneering platform, which uses AI-driven 3D spatial multimodal research to build predictive, high-fidelity models of a patient’s disease at the molecular level.
The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume.